Contraline is a startup based in the United States, most recent round Series B, 3 tracked investors.
Contraline is a startup based in the United States. Its most recent tracked round is Series B. Brouky records 3 investors associated with the company.
Contraline develops novel male contraceptive products, including a long-lasting, non-hormonal implant and a daily topical gel, to provide men with safe, effective, and reversible birth control options.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.